Valuation
- Market cap
- 2,143,822,000
- Revenue TTM
- $10,266,000,000
- Net income TTM
- $157,000,000
- PE ratio
- 1.36
- Forward PE
- 1.34
- Profit margin
- 1.53%
- Debt to equity
- -25.86
Trading
- Volume
- 3,281,300
- Avg volume
- 3,629,204
- Day's range
- $5.61 – $5.87
- Shares out
- 374,140,000
- Stochastic %K
- 68%
- Beta
- 0.37
- Analysts
- Sell
- Price target
- $7.58
Company profile
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry p...
Show more
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 514 744 6792
- Website
- https://www.bauschhealth.com
- Address
- 2150 St. Elzéar Blvd. West, Laval, Canada
Latest news
No headlines yet.
